These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 31139840)

  • 1. [Cannabis for medicinal use: development of pharmacopoeia monographs as a quality standard].
    Manns D; Norwig J; Reh K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):806-810. PubMed ID: 31139840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cannabis for medical purposes and its prescription].
    Kiefer A; Eckert-Lill C; Bussick D; Hörnig M; Reimann H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):811-817. PubMed ID: 31187182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality standards of the European Pharmacopoeia.
    Bouin AS; Wierer M
    J Ethnopharmacol; 2014 Dec; 158 Pt B():454-7. PubMed ID: 25043777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality Requirements for Medicinal Cannabis and Respective Products in the European Union - Status Quo.
    Veit M
    Planta Med; 2023 Jul; 89(8):808-823. PubMed ID: 35338476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microbiological and biological methods of the European Pharmacopoeia. Relevant for each medicinal product].
    Norwig J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1158-68. PubMed ID: 25200487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
    Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
    J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensuring the quality of medicines in India: An update on the development, modernization, and harmonization of drug standards in the Indian Pharmacopoeia.
    Jadaun GPS; Rastogi S; Kumar A; Chauhan J; Sharma SK; Kumar M; Saini PK; Tiwari R; Raghuvanshi RS
    Saudi Pharm J; 2023 Dec; 31(12):101825. PubMed ID: 37965488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cannabis for medical purposes : Impact of the law of 6 March 2017 on physicians].
    Cremer-Schaeffer P; Knöss W; Broich K
    Schmerz; 2019 Oct; 33(5):378-383. PubMed ID: 31243538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Certification of suitability of monographs of the European pharmacopoeia].
    Artiges A
    Ann Pharm Fr; 2002 Sep; 60(5):333-40. PubMed ID: 12378143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elaborating European Pharmacopoeia monographs for biotherapeutic proteins using substances from a single source.
    Buda M; Wicks S; Charton E
    Pharmeur Bio Sci Notes; 2016; 2016():129-134. PubMed ID: 28279254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key elements of legal environments for medical use of cannabis in different countries.
    Knöss W; van de Velde M; Sandvos C; Cremer-Schaeffer P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):855-860. PubMed ID: 31165903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A; Pieters L; Apers S
    Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regulatory take on cannabis and cannabinoids for medicinal use in the European Union.
    Lipnik-Štangelj M; Razinger B
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):12-18. PubMed ID: 32597142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ayurvedic Pharmacopoeia of India, development and perspectives.
    Joshi VK; Joshi A; Dhiman KS
    J Ethnopharmacol; 2017 Feb; 197():32-38. PubMed ID: 27404231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacopoeia as quality codex for the manufacturers.
    Soldi A
    Ann Ist Super Sanita; 1975; 11(3-4):269-80. PubMed ID: 1234728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of herbal/botanical monograph in international registration of Chinese medicine].
    Yang Y; Zhao SN; Zhang XT; Sun JW; Bai J; Yang LH
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3392-3396. PubMed ID: 35851134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on formation of medical cannabis market in Ukraine based on holistic approach.
    Aliekperova N; Kosyachenko К; Kaniura O
    J Cannabis Res; 2020 Oct; 2(1):33. PubMed ID: 33526139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current findings on the heavy metal content in herbal drugs.
    Gasser U; Klier B; Kühn AV; Steinhoff B
    Pharmeur Sci Notes; 2009 Mar; 2009(1):37-50. PubMed ID: 19275871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.